scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203317692437 |
P698 | PubMed publication ID | 28420054 |
P50 | author | Ellen M Ginzler | Q91640182 |
Susan Manzi | Q111603941 | ||
Kenneth C. Kalunian | Q111604424 | ||
Mary Anne Dooley | Q111604480 | ||
Ronald van Vollenhoven | Q47265013 | ||
Michael Mahler | Q49724482 | ||
Caroline Gordon | Q58049734 | ||
Diane Kamen | Q58664617 | ||
Marvin J Fritzler | Q63302292 | ||
Graciela S Alarcón | Q67485107 | ||
Michelle A. Petri | Q67485110 | ||
Rosalind Ramsey-Goldman | Q67485111 | ||
Joan T Merrill | Q67485131 | ||
Munther A. Khamashta | Q73418907 | ||
Sasha Bernatsky | Q87985660 | ||
Cynthia Aranow | Q91409089 | ||
Dafna D. Gladman | Q37605821 | ||
Guillermo Ruiz-Irastorza | Q37830875 | ||
David A. Isenberg | Q42326409 | ||
Manuel Ramos-casals | Q42646201 | ||
Christine A Peschken | Q43020820 | ||
P2093 | author name string | A Rahman | |
D J Wallace | |||
S Jacobsen | |||
O Nived | |||
J G Hanly | |||
K Steinsson | |||
A E Clarke | |||
P Fortin | |||
J Sanchez-Guerrero | |||
M B Urowitz | |||
M Inanc | |||
S S Lim | |||
J Romero-Diaz | |||
S-C Bae | |||
A Askanase | |||
J Buyon | |||
M Y Choi | |||
I N Bruce | |||
A A Zoma | |||
Y St Pierre | |||
P2860 | cites work | Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation | Q22008025 |
LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells | Q24304259 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2 | Q33361237 | ||
Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases | Q46228790 | ||
Anti-DFS70 antibodies in 597 healthy hospital workers | Q47948523 | ||
DFS70 Autoantibodies are Rare in Healthy Danish Individuals but may Still Serve as a Diagnostic Aid. | Q50568340 | ||
Towards a better understanding of the clinical association of anti-DFS70 autoantibodies | Q34502449 | ||
Anti-C1q antibodies in systemic lupus erythematosus | Q34717540 | ||
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies | Q35140485 | ||
Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden | Q35620360 | ||
Thrombophilia Associated with Anti-DFS70 Autoantibodies | Q35784744 | ||
Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey | Q37080599 | ||
Epitope specificity and significance in systemic autoimmune diseases | Q37690390 | ||
The Systemic Lupus International Collaborating Clinics (SLICC) group - it was 20 years ago today | Q37957814 | ||
The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases | Q38072928 | ||
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies | Q38152619 | ||
DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer | Q38410970 | ||
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing | Q38674581 | ||
Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells | Q38813885 | ||
Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence | Q38827609 | ||
Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies | Q39716599 | ||
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls | Q40425946 | ||
Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis | Q40511437 | ||
Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort | Q43240907 | ||
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. | Q43717482 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases | Q44849932 | ||
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort | Q45345442 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
P304 | page(s) | 1051-1059 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients | |
P478 | volume | 26 |
Q94570068 | Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association |
Q90465816 | Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort |
Q39454840 | Emerging technologies in autoantibody testing for rheumatic diseases |
Q55100401 | Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital. |
Q90309960 | Shared and unique immune alterations in pre-clinical autoimmunity |
Q90003817 | Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions |
Search more.